Alba Gonzalez-Junca

Alba Gonzalez-Junca currently serves as Associate Director at ArsenalBio, having joined the company in March 2023. Prior to this role, Gonzalez-Junca held various positions at Senti Biosciences from March 2017 to March 2023, including Director of Preclinical Research and Senior Scientist in Cancer Immunotherapy. Previous experience includes a postdoctoral researcher position at the University of California, San Francisco, in the Radiation Oncology Department from January 2016 to July 2018, and a similar role at NYU Langone Medical Center from March 2014 to January 2016. Gonzalez-Junca completed a PhD at Universitat de Barcelona, specializing in Biomedicine, following an International Master's in Neuroscience. Early research involvement includes roles as an undergraduate student researcher at Cancer Research UK, IMIM, and the American University of Beirut.